In contrast, our study provides further evidence that anti-ANO2 antibodies are specifically elevated in a subset of MS patients and correlate with anti EBNA1 (AA425-444) indicative for the described cross reactivity between both antigens. The gene discussed is ANO2; the disease is myeloid sarcoma.